Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 411

    1.

    'A matter of faith, not science': analysis of media coverage of prostate cancer screening in Australian news media 2003-2006.

    MacKenzie R, Chapman S, Holding S, McGeechan K.

    J R Soc Med. 2007 Nov;100(11):513-21.PMID: 18048709 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    "The news is [not] all good": misrepresentations and inaccuracies in Australian news media reports on prostate cancer screening.

    MacKenzie R, Chapman S, Barratt A, Holding S.

    Med J Aust. 2007 Nov 5;187(9):507-10.PMID: 17979615 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

    Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

    Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.PMID: 18678846 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A national survey of medical students' beliefs and knowledge in screening for prostate cancer.

    Marcella S, Delnevo CD, Coughlin SS.

    J Gen Intern Med. 2007 Jan;22(1):80-5.PMID: 17351844 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.

    Lim LS, Sherin K; ACPM Prevention Practice Committee.

    Am J Prev Med. 2008 Feb;34(2):164-70. Review. Erratum in: Am J Prev Med. 2008 May;34(5):454. PMID: 18201648 [PubMed - indexed for MEDLINE]Related articles

    8.

    A community study using specified and unspecified scenarios to investigate men's views about PSA screening.

    Gattellari M, Ward JE.

    Health Expect. 2004 Dec;7(4):274-89.PMID: 15544681 [PubMed - indexed for MEDLINE]Related articles

    9.

    Screening for prostate cancer: explaining new trial results and their implications to patients.

    Barratt AL, Stockler MR.

    Med J Aust. 2009 Aug 17;191(4):226-9.PMID: 19705986 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prostate cancer and prostate-specific antigen testing in New South Wales.

    Smith DP, Supramaniam R, Marshall VR, Armstrong BK.

    Med J Aust. 2008 Sep 15;189(6):315-8.PMID: 18803534 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach.

    Etzioni R, Gulati R, Falcon S, Penson DF.

    Med Decis Making. 2008 May-Jun;28(3):323-31. Epub 2008 Mar 4.PMID: 18319508 [PubMed - indexed for MEDLINE]Related articles

    12.

    Screening men for prostate cancer and colorectal cancer: is practice evidence-based?

    Chun FK, Suardi N, Perrotte P, Lebeau T, Guay JP, Benayoun S, Ramirez A, Bénard F, McCormack M, Valiquette L, Karakiewicz P.

    Can J Urol. 2007 Dec;14(6):3727-33.PMID: 18163923 [PubMed - indexed for MEDLINE]Related articles

    13.

    Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC.

    Schröder FH, Bangma CH, Roobol MJ.

    Eur Urol. 2008 May;53(5):901-8. Epub 2008 Jan 28.PMID: 18262712 [PubMed - indexed for MEDLINE]Related articles

    14.

    Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.

    Freedland SJ, Sun L, Kane CJ, Presti JC Jr, Terris MK, Amling CL, Moul JW, Aronson WJ.

    BJU Int. 2008 Sep;102(8):969-74. Epub 2008 Aug 7.PMID: 18691175 [PubMed - indexed for MEDLINE]Related articles

    15.

    Update on PSA testing.

    Gonzalgo ML, Carter HB.

    J Natl Compr Canc Netw. 2007 Aug;5(7):737-42. Review.PMID: 17692178 [PubMed - indexed for MEDLINE]Related articles

    16.

    Why men with prostate cancer want wider access to prostate specific antigen testing: qualitative study.

    Chapple A, Ziebland S, Shepperd S, Miller R, Herxheimer A, McPherson A.

    BMJ. 2002 Oct 5;325(7367):737.PMID: 12364299 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Quantifying the role of PSA screening in the US prostate cancer mortality decline.

    Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, DiTommaso D, Karnofski K, Gulati R, Penson DF, Feuer E.

    Cancer Causes Control. 2008 Mar;19(2):175-81. Epub 2007 Nov 20.PMID: 18027095 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prostate cancer, the PSA test and academic detailing in Australian general practice: an economic evaluation.

    Stone CA, May FW, Pinnock CB, Elwood M, Rowett DS.

    Aust N Z J Public Health. 2005 Aug;29(4):349-57.PMID: 16222933 [PubMed - indexed for MEDLINE]Related articles

    19.

    PSA use and incidence of prostate biopsy in the Tuscany region: is opportunistic screening discounting biopsy in subjects with PSA elevation?

    Ciatto S, Houssami N, Martinelli F, Giusti F, Zappa M.

    Tumori. 2008 Jul-Aug;94(4):518-22.PMID: 18822688 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.

    Ross LE, Berkowitz Z, Ekwueme DU.

    Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):636-44.PMID: 18349281 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data